Infinium Pharmachem Limited (NSE:INFINIUM)
India
· Delayed Price · Currency is INR 316.25
-9.10 (-2.80%)
At close: May 27, 2025
Infinium Pharmachem Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 |
| Operating Revenue | 1,356 | 1,142 | 991.19 | 545.58 | 360.38 | Upgrade
|
| Other Revenue | - | - | - | 2.01 | 3.9 | Upgrade
|
| Revenue | 1,356 | 1,142 | 991.19 | 547.59 | 364.29 | Upgrade
|
| Revenue Growth (YoY) | 18.75% | 15.24% | 81.01% | 50.32% | 100.77% | Upgrade
|
| Cost of Revenue | 1,040 | 810.2 | 769.18 | 397.69 | 276.5 | Upgrade
|
| Gross Profit | 316.25 | 332.05 | 222.01 | 149.9 | 87.79 | Upgrade
|
| Selling, General & Admin | 65.86 | 57.95 | 38.23 | 23.79 | 20.51 | Upgrade
|
| Other Operating Expenses | 64.48 | 113.54 | 82.27 | 74.59 | 36.35 | Upgrade
|
| Operating Expenses | 157.02 | 184.88 | 127.88 | 104.89 | 62.67 | Upgrade
|
| Operating Income | 159.23 | 147.16 | 94.13 | 45.01 | 25.11 | Upgrade
|
| Interest Expense | -18.87 | -27.94 | -14.4 | -9.16 | -5.34 | Upgrade
|
| Interest & Investment Income | 1.82 | 0.2 | 0.3 | 0.18 | 0.32 | Upgrade
|
| Currency Exchange Gain (Loss) | 6.87 | 9.97 | 2.08 | 3.63 | 0.76 | Upgrade
|
| Other Non Operating Income (Expenses) | 3.06 | 0.15 | 4.21 | -2.08 | -6.96 | Upgrade
|
| EBT Excluding Unusual Items | 152.1 | 129.53 | 86.32 | 37.58 | 13.89 | Upgrade
|
| Pretax Income | 152.1 | 129.53 | 86.32 | 37.58 | 13.89 | Upgrade
|
| Income Tax Expense | 37.07 | 31.36 | 19.47 | 10.39 | 3.71 | Upgrade
|
| Earnings From Continuing Operations | 115.03 | 98.17 | 66.86 | 27.19 | 10.18 | Upgrade
|
| Minority Interest in Earnings | -2.01 | -3.27 | -5.79 | - | - | Upgrade
|
| Net Income | 113.02 | 94.9 | 61.06 | 27.19 | 10.18 | Upgrade
|
| Net Income to Common | 113.02 | 94.9 | 61.06 | 27.19 | 10.18 | Upgrade
|
| Net Income Growth | 19.10% | 55.41% | 124.55% | 167.10% | 152.93% | Upgrade
|
| Shares Outstanding (Basic) | 14 | 10 | 10 | 10 | 10 | Upgrade
|
| Shares Outstanding (Diluted) | 14 | 10 | 10 | 10 | 10 | Upgrade
|
| Shares Change (YoY) | 36.89% | - | - | - | - | Upgrade
|
| EPS (Basic) | 8.12 | 9.33 | 6.01 | 2.67 | 1.00 | Upgrade
|
| EPS (Diluted) | 8.12 | 9.33 | 6.01 | 2.67 | 1.00 | Upgrade
|
| EPS Growth | -13.01% | 55.41% | 124.55% | 167.23% | 152.81% | Upgrade
|
| Free Cash Flow | -165.55 | 11.23 | 70.69 | 22.11 | 12.18 | Upgrade
|
| Free Cash Flow Per Share | -11.90 | 1.10 | 6.95 | 2.17 | 1.20 | Upgrade
|
| Gross Margin | 23.32% | 29.07% | 22.40% | 27.37% | 24.10% | Upgrade
|
| Operating Margin | 11.74% | 12.88% | 9.50% | 8.22% | 6.89% | Upgrade
|
| Profit Margin | 8.33% | 8.31% | 6.16% | 4.97% | 2.79% | Upgrade
|
| Free Cash Flow Margin | -12.21% | 0.98% | 7.13% | 4.04% | 3.34% | Upgrade
|
| EBITDA | 185.91 | 160.55 | 100.44 | 51.52 | 30.92 | Upgrade
|
| EBITDA Margin | 13.71% | 14.06% | 10.13% | 9.41% | 8.49% | Upgrade
|
| D&A For EBITDA | 26.68 | 13.39 | 6.31 | 6.51 | 5.81 | Upgrade
|
| EBIT | 159.23 | 147.16 | 94.13 | 45.01 | 25.11 | Upgrade
|
| EBIT Margin | 11.74% | 12.88% | 9.50% | 8.22% | 6.89% | Upgrade
|
| Effective Tax Rate | 24.37% | 24.21% | 22.55% | 27.64% | 26.70% | Upgrade
|
| Revenue as Reported | 1,372 | 1,156 | 1,001 | 551.81 | 366.13 | Upgrade
|
| Advertising Expenses | 6.75 | 4.24 | 2.83 | 1.68 | 1.97 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.